Evidence map›Paper›PMID 33141812›Full record

ArticleThe American journal of case reports2020

Efficacy of Hyperthermia in Treatment of Recurrent Metastatic Breast Cancer After Long-Term Chemotherapy: A Report of 2 Cases.

Hirozumi Sawai, Masaaki Kurimoto, Yuka Suzuki, Yoshimi Yamaguchi, Akemi Murata, Enami Suganuma, Kazuya Yamamoto, Hiromasa Kuzuya, Shuhei Ueno, Shuji Koide and 2 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. FeIn vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hirozumi SawaiDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Masaaki KurimotoDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Yuka SuzukiDepartment of Medical Technique (Radiological Technology), Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Yoshimi YamaguchiDepartment of Medical Technique (Radiological Technology), Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Akemi MurataDepartment of Medical Technique (Radiological Technology), Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Enami SuganumaDepartment of Medical Technique (Radiological Technology), Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Kazuya YamamotoDepartment of Medical Technique (Radiological Technology), Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Hiromasa KuzuyaDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Shuhei UenoDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Shuji KoideDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Hajime KoideDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Atsushi KamiyaDepartment of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Breast cancer has a long-term prognosis with various multimodality treatments. This report introduces the effectiveness of radiofrequency (RF) hyperthermia in the long-term treatment for recurrent/metastatic breast cancer. CASE REPORT In the first case, the patient had bone and liver metastases during the course of chemotherapy, hormone therapy, and radiotherapy for 27 years after curative resection of breast cancer. Finally, she received RF hyperthermia alone for liver metastasis and showed a decrease in tumor markers and reduction in liver metastasis on computed tomography (CT). In the second case, the patient underwent curative resection for multiple occurrences on the left side of the breast. She received postoperative chemotherapy combined with hormone therapy but had metachronous local recurrences. She continued hormone therapy after 2 local recurrence resections; unfortunately, she had bone, liver, and lung metastases and pleural dissemination. Eventually, the patient received RF hyperthermia combined with oral chemotherapy. Her tumor markers decreased, and CT showed disappearance of lung metastasis and improved pleural dissemination. Furthermore, the reduction of chemotherapy adverse events due to hyperthermia allowed the patient to continue chemotherapy and improved her quality of life. CONCLUSIONS We present 2 cases in which RF hyperthermia had a positive effect despite the presence of a recurrent tumor after various types of surgery, chemotherapy, and radiotherapy. This report suggests that the addition of RF hyperthermia to conventional multidisciplinary therapies may enhance the therapeutic effect of these treatments and improve the quality of life in patients with recurrent breast cancer.

Indexed as

Breast NeoplasmsHyperthermia, InducedCombined Modality TherapyFemaleHumansHyperthermiaNeoplasm Recurrence, LocalQuality of Life

Identifiers

PMID33141812
PMCPMC7649113
OpenAlexW3097445198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.